← 홈

Antibody

1,830개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,830개
AntibodystaleShuhong YiPhase 2

atezolizumab (Tecentriq, Hepatic arterial infusion chemotherapy + Atezolizumab and bevacizumab)

Recurrent Liver Cancer After Liver Transplantation · Recurrent Liver Cancer After Liver Trans

#RecurrentLiverCancerAfterLiverTr#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

trastuzuamb (Herceptin, Herceptin (trastuzuamb))

HER2 Positive Early or Locally Advanced Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
효능 ORR 91.2%임상시험 1상태 ACTIVE
AntibodystaleRochePreclinical

trastuzumab (Herceptin, Herceptin (trastuzumab))

Breast Neoplasms · Breast Neoplasms

#BreastNeoplasms#Antibody#Preclinical#항체#면역항체+2
효능 ORR 91.2%임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 1

trastuzumab (Herceptin, Herceptin EU)

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

trastuzumab (Herceptin, Herceptin Hylecta®)

Healthy Male Participants · Healthy Male Participants

#HealthyMaleParticipants#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 1

trastuzumab (Herceptin, Herceptin US)

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Herceptin+XELOX)

Metastatic or Recurrent Gastric Adenocarcinoma; Her-2 Positive Gastric Cancer · Metastatic or Recurrent Gastric Adenocar

#MetastaticorRecurrentGastricAden#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

High-dose Epirubicin Combined with CVP ± Rituximab (High-dose Epirubicin Combined with CVP ± Rituximab)

Diffuse Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleWeill Medical College of Cornel…Phase 3

Higher Dose of Rituximab (Higher Dose of Rituximab)

Immune Thrombocytopenic Purpura · Immune Thrombocytopenic Purpura

#ImmuneThrombocytopenicPurpura#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 3

adalimumab (Humira, Human anti-TNF monoclonal antibody/adalimumab)

Psoriatic Arthritis · Psoriatic Arthritis

#PsoriaticArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 1

adalimumab-EU (Humira, Humira (adalimumab-EU))

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 1

adalimumab-US (Humira, Humira (adalimumab-US))

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 1

adalimumab (Humira, Humira®, Humira® (adalimumab) AC Pen [Reference Product])

Pharmacokinetics; Safety Issues · Pharmacokinetics

#Pharmacokinetics#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleHunan Province Tumor HospitalPhase 2

IBI-323 combined with bevacizumab plus Platinum (IBI-323 combined with bevacizumab plus Platinum)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleShanghai Pulmonary Hospital, Sh…Phase 2

IBI310+Sintilimab (IBI310+Sintilimab)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSecond Affiliated Hospital, Sch…Phase 2

IBI351, cetuximab β combined with FOLFIRI (IBI351, cetuximab β combined with FOLFIRI)

Colorectal Cancer Metastatic; KRAS G12C Mutation · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleBiogenPhase 2

rituximab (IDEC-C2B8, IDEC-C2B8 (rituximab))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleIkena OncologyPhase 1

nivolumab (Opdivo, IK-175 + nivolumab)

Head and Neck Squamous Cell Carcinoma; Head and Neck Cancer · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleIkena OncologyPhase 1

nivolumab (Opdivo, IK-175 and nivolumab)

Urothelial Carcinoma; Urothelial Carcinoma Bladder · Urothelial Carcinoma

#UrothelialCarcinoma#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodyBiologicstaleSecond Affiliated Hospital, Sch…Approved

IL-17A/F mAb + NAFL (IL-17A/F mAb + NAFL)

Hidradenitis Suppurativa (HS) · Hidradenitis Suppurativa (HS)

#HidradenitisSuppurativaHS#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING

49 / 92 페이지

← 이전다음 →